Shingles Vaccine Linked to Lower Dementia Risk: What You Demand to Grasp

One in three Americans will experience shingles in their lifetime, yet vaccination rates remain suboptimal. Now, a growing body of evidence suggests the Shingrix vaccine offers benefits beyond preventing the painful shingles rash – potentially reducing the risk of dementia, stroke, and heart attack. Despite the vaccine’s effectiveness, “there is a lot of what I call vaccine fatigue right now,” says Dr. Andrew Wallach, ambulatory care chief medical officer at NYC Health + Hospitals.

What is Shingles?

Shingles is a viral infection caused by the varicella-zoster virus, the same virus that causes chickenpox. After a chickenpox infection, the virus remains dormant in the body and can reactivate later in life as shingles, typically after age 50. Unlike chickenpox, shingles manifests as a painful rash and blisters that usually appear on one side of the body, often as a stripe. Symptoms include pain, sensitivity to touch, itching, fever, headache, and fatigue. While generally clearing within two to four weeks, complications can occur in 1-4% of cases, particularly in older adults and those with weakened immune systems.

How Does Vaccination Prevent Shingles?

Vaccination significantly reduces the risk of both chickenpox and shingles. In the US, the Shingrix vaccine is recommended for adults 50 years and older and is over 90% effective at preventing shingles in healthy individuals. Even if shingles does occur in vaccinated individuals, the vaccine can lessen the severity of the illness and reduce the risk of complications like postherpetic neuralgia, a long-lasting nerve pain.

The Link Between Shingles Vaccination and Dementia Risk

Recent research has uncovered a compelling association between shingles vaccination and a reduced risk of dementia. A 2026 study led by Dr. Emily Rayens at Kaiser Permanente Southern California found a 51% reduction in dementia risk among individuals vaccinated with Shingrix, even after accounting for socioeconomic status and lifestyle factors.

Experts propose two potential mechanisms for this protective effect. First, persistent viruses like varicella-zoster may contribute to chronic immune system stress and neuroinflammation, potentially increasing dementia risk. Second, the immune-boosting effects of vaccination may extend beyond the targeted virus, offering broader protection against neurological diseases. Dr. Pascal Geldsetzer, assistant professor of medicine at Stanford University, is currently raising funds for a clinical trial to further investigate these mechanisms and establish a causal link.

Beyond Dementia: Potential Cardiovascular Benefits

The benefits of shingles vaccination may extend beyond neurological health. A 2025 review of 19 studies indicated that shingles vaccination was associated with a lower risk of both stroke and heart attack. This suggests a potential cardiovascular protective effect, though further research is needed to confirm this link.

Shingles Vaccine Side Effects and Eligibility

The CDC reports that Shingrix has no serious side effects, though some individuals may experience pain and swelling at the injection site, or mild flu-like symptoms. These side effects are typically mild and resolve within a few days, and are often less pronounced in adults over 70.

The CDC recommends two doses of Shingrix, spaced two to six months apart, for adults 50 and older. Adults with weakened immune systems aged 19 and older are also recommended to receive the vaccine, with a shorter interval of one to two months between doses. Individuals currently experiencing shingles, who are pregnant, or who have had an allergic reaction to Shingrix should not be vaccinated.

Treating Shingles

If you develop shingles, antiviral medications are the primary treatment and are most effective when started within 72 hours of the rash appearing. Other supportive treatments include over-the-counter pain relievers, calamine lotion, and cool compresses. Keeping the rash clean and dry is also essential.